CereVasc, Inc. announced it has received its second FDA Breakthrough Device designation for the investigational eShunt system ...

Medtronic announced the primary and secondary outcomes of the VenaSeal Spectrum Venous Leg Ulcer study. According to the ...

Surmodics, Inc. announced the publication of results from the TRANSCEND clinical trial. The global randomized study ...

Cordis announced new data from the SUCCESS PTA and SELUTION SFA Japan peripheral studies evaluating the company’s Selution ...

Efemoral Medical announced the presentation of long-term results from the initial 20 patients enrolled across four sites in ...

IceCure Medical Ltd. announced findings from three investigator-initiated studies of the company’s ProSense system for the ...

Perfuze, an Ireland-based developer of catheter-based technology for the treatment of acute ischemic stroke, announced the ...

With a focus on endovascular aneurysm repair (EVAR) for abdominal aortic aneurysms (AAAs) and thoracoabdominal aortic ...

Medtronic announced the release of data from a subgroup analysis of an atherectomy systematic literature review (SLR) that is eva ...

Venova Medical announced the completion of patient enrollment for the company’s VENOS-2 early feasibility study. Accordi ...

Vivasure Medical, an Ireland-based developer of fully absorbable technology for percutaneous vessel closure, announced ...